Overview

Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prove safety and efficacy of aripiprazole.
Phase:
Phase 4
Details
Lead Sponsor:
Korea Otsuka Pharmaceutical Co., Ltd.
Treatments:
Aripiprazole